- SGMO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Sangamo Therapeutics (SGMO) 10-K/A2003 FY Annual report (amended)
Filed: 27 Apr 04, 12:00am
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration Statements (Form S-8 No. 333-34196 and 333-64642) and in the Registration Statements (Form S-3 No. 333-113062 and 333-68066) and in the related prospectuses of Sangamo BioSciences, Inc. of our report dated January 30, 2004, Except for Note 2, as it relates to research costs and expenses, as to which the date is April 26, 2004, with respect to the consolidated financial statements of Sangamo BioSciences, Inc. included in its Annual Report (Amendment No. 2 to Form 10-K/A) for the year ended December 31, 2003.
/s/ ERNST & YOUNG LLP
Palo Alto, California
April 26, 2004
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.